KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Inventory: 2018-2025

Historic Change in Inventory for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Sep 2025 value amounting to -$188,000.

  • Rigel Pharmaceuticals' Change in Inventory rose 94.38% to -$188,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 453.36%. This contributed to the annual value of -$764,000 for FY2024, which is 34.81% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Change in Inventory is -$188,000, which was down 102.25% from $8.4 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Inventory peaked at $8.4 million during Q2 2025, and registered a low of -$3.3 million during Q3 2024.
  • In the last 3 years, Rigel Pharmaceuticals' Change in Inventory had a median value of -$281,000 in 2023 and averaged $439,091.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 2,078.51% in 2021, then tumbled by 1,090.04% in 2024.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Change in Inventory stood at -$450,000 in 2021, then spiked by 540.67% to $2.0 million in 2022, then slumped by 227.63% to -$2.5 million in 2023, then increased by 23.94% to -$1.9 million in 2024, then surged by 94.38% to -$188,000 in 2025.
  • Its last three reported values are -$188,000 in Q3 2025, $8.4 million for Q2 2025, and -$1.4 million during Q1 2025.